DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Part of paid clinical trials in Mesa, Arizona.

Sponsor
Barnet Dulaney Perkins Eye Centers
Study ID
NCT06933836
Status
Recruiting
Apply to this trial

Conditions

  • Open Angle Glaucoma (OAG)

Eligibility Criteria

Sex
ALL
Age
30 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • DSLT enables newly diagnosed patients to remain well controlled and off medications — DEVICE
    DSLT enables newly diagnosed patients to remain well controlled and off medications

Study Details

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Key Dates

Start date
Mar 31, 2025
Status verified
Mar 2025
Primary completion
Nov 30, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
55 participants (estimated)

Arms

  • Arm: Treatment naïve (including medication in either eye, previous laser or surgery) mild to moderate POA
    (including medication in either eye, previous laser or surgery) mild to moderate POA

Primary Outcome Measure

Success of IOP Reduction Through DSLT Utilization [ Time Frame: 12 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Barnet Dulaney Perkins Eye CentersMesaArizona85206
Derek J Arnson, Master of Education
[email protected]
4804201005
Christine Funke, Medical Doctor
[email protected]
4804201005
Christine Funke, Medical Doctor (PRINCIPAL_INVESTIGATOR)

Find similar trials in Mesa, AZ

By research site
Barnet Dulaney Perkins Eye Centers· Mesa, AZ

Related Studies